医学
阶段(地层学)
肺癌
放射科
腺癌
癌症
人口
肺
外科
内科学
古生物学
环境卫生
生物
作者
Hua Zhong,Feng Yao,Q H Chen,Jindong Guo,L C Zhang,Yong Zhang,Bingxu Han
出处
期刊:PubMed
[National Institutes of Health]
日期:2023-06-23
卷期号:45 (6): 455-463
被引量:3
标识
DOI:10.3760/cma.j.cn112152-20220606-00390
摘要
CT screening has markedly reduced the lung cancer mortality in high-risk population and increased the detection of early-stage pulmonary neoplasms, including multiple pulmonary nodules, especially those with a ground-glass appearance on CT. Multiple primary lung cancer (MPLC) constitutes a specific subtype of lung cancer with indolent biological behaviors, which is predominantly early-stage adenocarcinoma. Although MPLC progresses slowly with rare lymphatic metastasis, existence of synchronous lesions and distributed location of these nodules still pose difficulty for the management of such patients. One single operation is usually insufficient to eradicate all neoplastic lesions, whereas repeated surgical procedures bring about another dilemma: whether clinical benefits of surgical treatment outweigh loss of pulmonary function following multiple operations. Therefore, despite the anxiety for treatment among MPLC patients, whether and how to treat the patient should be assessed meticulously. Currently there is a heated discussion upon the timing of clinical intervention, operation mode and the application of local therapy in MPLC. Based on clinical experience of our multiple disciplinary team, we have summarized and commented on the evaluation, surgical treatment, non-surgical local treatment, targeted therapy and immunotherapy of MPLC in this article to provide further insight into this field.
科研通智能强力驱动
Strongly Powered by AbleSci AI